The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens

被引:122
作者
Dankers, MKA
Witvliet, MD
Roelen, DL
De Lange, P
Korfage, N
Persijn, GG
Duquesnoy, R
Doxiadis, IIN
Claas, FHJ
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands
[2] Eurotransplant Fdn, Leiden, Netherlands
[3] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
关键词
D O I
10.1097/01.TP.0000120385.03278.28
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The correlation between antibody production against mismatched donor human leukocyte antigens (HLA) and the number of amino acid sequence mismatches was analyzed in patients who rejected a kidney transplant (n=146). Methods. A similar analysis was performed for the antibody production of women against the paternal HLA antigens of their child (n = 1,397). The amino acid sequence (triplet) differences were analyzed using the HLAMatchmaker algorithm. Results. In both groups, a positive correlation was found between the number of triplet mismatches and the percentage of individuals producing antibodies (P<0.0001). If zero triplet mismatches were present, no antibodies were formed in all cases. When 11 or 12 triplet mismatches were present, 94% of the transplant patients produced antibodies against the donor. In pregnancy, 11 or 12 triplet mismatches led to 27% of the women producing specific antibodies. Conclusions. These results indicate that the immunogenicity of the fetus is lower than that of a rejected kidney and that analysis of the number of triplet mismatches can predict the antibody reactivity against the mismatched HLA antigens.
引用
收藏
页码:1236 / 1239
页数:4
相关论文
共 12 条
  • [1] Cytokine promoter gene polymorphisms and idiopathic recurrent pregnancy loss
    Babbage, SJ
    Arkwright, PD
    Vince, GS
    Perrey, C
    Pravica, V
    Quenby, S
    Bates, M
    Hutchinson, IV
    [J]. JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2001, 51 (01) : 21 - 27
  • [2] Borel IM, 1996, AM J REPROD IMMUNOL, V35, P529
  • [3] Predictive parameters for in vivo alloreactivity
    Claas, FHJ
    [J]. TRANSPLANT IMMUNOLOGY, 2002, 10 (2-3) : 137 - 142
  • [4] The HLA-DR phenotype of the responder is predictive of humoral response against HLA class I antigens
    Dankers, MKA
    Roelen, DL
    Nagelkerke, NJD
    de Lange, P
    Persijn, GG
    Doxiadis, IIN
    Claas, FHJ
    [J]. HUMAN IMMUNOLOGY, 2004, 65 (01) : 13 - 19
  • [5] Differential immunogenicity of paternal HLA class I antigens in pregnant women
    Dankers, MKA
    Roelen, DL
    Korfage, N
    de Lange, P
    Witvliet, M
    Sandkuijl, L
    Doxiadis, IIN
    Claas, FHJ
    [J]. HUMAN IMMUNOLOGY, 2003, 64 (06) : 600 - 606
  • [6] Differential immunogenicity of HLA mismatches: HLA-A2 versus HLA-A28
    Dankers, MKA
    Roelen, DL
    Van Der Meer-Prins, EMW
    De Lange, P
    Korfage, N
    Smits, JMA
    Persijn, GG
    Welsh, KI
    Doxiadis, IIN
    Claas, FHJ
    [J]. TRANSPLANTATION, 2003, 75 (03) : 418 - 420
  • [7] HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival
    Duquesnoy, RJ
    Takemto, S
    de Lange, P
    Doxiadis, IIN
    Schreuder, GMT
    Persijn, GG
    Claas, FHJ
    [J]. TRANSPLANTATION, 2003, 75 (06) : 884 - 889
  • [8] HLAMatchmaker: A molecularly based algorithm for histocompatibility determination. I. Description of the algorithm
    Duquesnoy, RJ
    [J]. HUMAN IMMUNOLOGY, 2002, 63 (05) : 339 - 352
  • [9] The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces
    Guller, S
    LaChapelle, L
    [J]. SEMINARS IN REPRODUCTIVE ENDOCRINOLOGY, 1999, 17 (01): : 39 - 44
  • [10] HEAD JR, 1987, AM J REPROD IMMUNOL, V15, P12